Metastatic castration-resistant prostate cancer and the challenge of a patient with chronic kidney disease in hemodialysis
Autops. Case Rep
;
8(2): e2018011, Apr.-May 2018. ilus graf
Article
in English
| LILACS
| ID: biblio-905587
ABSTRACT
At a time when the population shows increasing longevity, entities such as cancer and chronic kidney disease (CKD) are more frequently connected. In the United States, approximately 6% of the patients on hemodialysis have cancer. The challenge to manage oncologic patients with CKD in a hemodialytic program represents a great shortage of available information on the choice of the best drug, timing, dosage adjustments, dialysis method, and treatment safety. We present the case of a patient with prostate cancer and terminal CKD in hemodialysis, and the treatment sequence after the development of resistance to hormonal blockade therapy, which included docetaxel, enzalutamide, and radium-223.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Prostatic Neoplasms
/
Adenocarcinoma
/
Dialysis
/
Renal Insufficiency, Chronic
/
Antineoplastic Agents
Limits:
Humans
/
Male
Language:
English
Journal:
Autops. Case Rep
Journal subject:
Anatomia
/
Patologia Cl¡nica
/
Patologia Legal
Year:
2018
Type:
Article
Affiliation country:
Portugal
Institution/Affiliation country:
University of Porto/PT
Similar
MEDLINE
...
LILACS
LIS